Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Plos Pathogens|December 2, 2021
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccinationChris Davis, Nicola Logan, Grace Tyson, et al.The Journal of Infectious Diseases|December 28, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare SettingEllen C Hughes, Julien A R Amat, Joanne Haney, et al.Scientific Reports|February 4, 2022
Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studiesMaryam Khan, Carolina Rosadas, Ksenia Katsanovskaja, et al.Nature Communications|August 17, 2017
A new class of hybrid secretion system is employed in Pseudomonas amyloid biogenesisSarah L Rouse, William J Hawthorne, Jamie-Lee Berry, et al.Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.Nature Communications|May 3, 2022
Multivalent interactions essential for lentiviral integrase functionAllison Ballandras-Colas, Vidya Chivukula, Dominika T Gruszka, et al.Biorxiv : the Preprint Server for Biology|February 19, 2024
Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1Sarah Griffith, Luke Muir, Ondrej Suchanek, et al.Nature Communications|November 14, 2023
Multiplexed detection of viral antigen and RNA using nanopore sensing and encoded molecular probesRen Ren, Shenglin Cai, Xiaona Fang, et al.Research Square|June 9, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.Vaccines|October 28, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 VaccineAlberto Grandi, Michele Tomasi, Irfan Ullah, et al.Pageof 13